H.I.G. Capital News
-
DURHAM, NC - June 11, 2018 - HyperBranch Medical Technology, Inc. announced today that on June 8, 2018, after a two-week trial in federal district court in Wilmington, Delaware, an 8-member jury found in favor of HyperBranch on all remaining claims and legal defenses at issue in a patent…
-
AUSTIN – May 8, 2018 - Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, announced today the establishment of a multicenter, longitudinal, data repository for Endoscopic Sleeve Gastroplasty…
-
MARLBOROUGH, MA – May 7, 2018 - CardioFocus, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted approval for the HeartLight Excalibur Balloon, a next-generation technology designed for the treatment of paroxysmal atrial fibrillation (PAF)*. The Excalibur…
-
AUSTIN - April 23, 2018 - Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced that the Saudi Food and Drug Authority (SFDA) has approved the ORBERA365™ Managed Weight…
-
WAYNE, PA – April 16, 2018 - Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that it closed a Series C financing totaling $20 million. This financing is designed to fund the Company through Pre-Market Approval…
-
WAYNE, PA – April 16, 2018 - Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that its Tack Optimized…
-
WEST LAFAYETTE, IN - April 5, 2018 – On Target Laboratories, Inc., a privately held biotechnology company that is developing tumor-targeted fluorescent dyes to improve cancer surgery, announced today that the first patient was treated in a Phase 3 clinical trial of OTL38 in the detection…
-
WAYNE, PA – March 27, 2018 - Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today welcomed the publication of the Tack Optimized Balloon Angioplasty Below the Knee (TOBA BTK) clinical trial results in the current issue…
-
WEST LAFAYETTE, IN - March 14, 2018 – On Target Laboratories, Inc., a privately held biotechnology company that is developing tumor-targeted fluorescent dyes to improve cancer surgery, has secured an additional financing as part of its Series B capital raise which initially closed…
-
February 26, 2018 - CardioFocus Announces Initiation of HeartLight® X3 Clinical Evaluation
MARLBOROUGH, MA – February 26, 2018 - CardioFocus, Inc., a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AF), today announced the initiation of a clinical evaluation of the new HeartLight X3 System…
-
WAYNE, PA – January 25, 2018 - Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced the Tack Optimized…
-
January 9, 2018 - CardioFocus® Announces Expanded Partnership with Japan Lifeline
MARLBOROUGH, MA – January 9, 2018 - CardioFocus, Inc., a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AF), today announced that it has entered into an expanded partnership with Japan Lifeline…
-
MARLBOROUGH, MA - November 29, 2017 - CardioFocus, Inc. today announced the successful completion of its controlled U.S. commercial launch of the HeartLight® Endoscopic Ablation System for the treatment of paroxysmal atrial fibrillation (AF). Ten leading cardiac centers across the…
-
AUSTIN - November 27, 2017 - Apollo Endosurgery, Inc. (“Apollo”) (NASDAQ:APEN), a leader in less invasive surgical medical devices for bariatric and gastrointestinal procedures, announced today U.S. Food and Drug Administration 510k clearance of the OverStitch Sx, a new, full-thickness…
-
ALISO VIEJO, CA - November 22, 2017 - RxSight, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved the RxSight™ Light Adjustable Lens and the Light Delivery Device (LDD) for patients with pre-existing astigmatism of ≥ 0.75 diopters undergoing cataract…
-
November 16, 2017 - David C. Pacitti Joins Apollo Endosurgery Board of Directors
AUSTIN - November 16, 2017 - The Board of Directors of Apollo Endosurgery, Inc. (“Apollo”) (NASDAQ:APEN), today announced the appointment of David C. Pacitti as an independent director of Apollo. He will commence service on December 8, 2017. Mr. Pacitti’s appointment expands the…
-
MARLBOROUGH, MA – September 27, 2017 - CardioFocus, Inc. today announced the European CE Mark approval of the HeartLight Excalibur Balloon, a next-generation technology designed for the treatment of atrial fibrillation (AF). The Excalibur Balloon leverages the proven universal balloon…
-
AUSTIN - August 31, 2017 - Apollo Endosurgery, Inc. (NASDAQ:APEN), a leader in less invasive surgical medical devices for bariatric and gastrointestinal procedures, announced the presentation of 20 year outcomes data for the LAP-BAND® System today at the 22nd World Congress of the…
-
August 22, 2017 - Iconic Therapeutics Appoints Brandon Smith Chief Operating Officer
SAN FRANCISCO - August 22, 2017 – Iconic Therapeutics, a clinical stage biopharmaceutical company dedicated to translating knowledge of Tissue Factor biology into new therapeutics for retinal disease and cancer, announced the appointment of Brandon Smith as Chief Operating Officer.…
-
MARLBOROUGH, MA - July 31, 2017 - CardioFocus, Inc. today announced that the Japanese Ministry of Health, Labour and Welfare has approved the HeartLight Endoscopic Ablation System for the treatment of paroxysmal atrial fibrillation (AF) in Japan. The HeartLight System is a visually…
-
July 20, 2017 - Apollo Endosurgery, Inc. Announces Pricing of $31 Million Public Offering
AUSTIN - July 20, 2017 - Apollo Endosurgery, Inc. (NASDAQ: APEN), a medical technology company primarily focused on the design, development and commercialization of innovative medical devices that can be used for the treatment of obesity, today announced the pricing of an underwritten…
-
WAYNE, PA - July 18, 2017 - Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that its Tack Optimized…